Cerevel Therapeutics Holdings, Inc.
CERE
Revenue
0.00
0.000.00%
12 Months ChangeAssets
1.13B
▼-115.96M▼-9.33%
3 Months ChangeLiabilities
562.89M
▼-6.67M▼-1.17%
3 Months ChangeFree Cash Flow
-119.94M
▼-24.68M▼-25.91%
12 Months ChangeRevenue/Cost Of Revenue
Revenue
Cost Of Revenue
Loading...
| Date | Revenue | Cost Of Revenue |
|---|---|---|
Net Profit/Loss
Net Profit/Loss
Baseline
Loading...
| Date | Net Profit/Loss |
|---|---|
Assets/Liabilities
Assets
Liabilities
Loading...
| Date | Assets | Liabilities |
|---|---|---|
Cash Flows
Operating (Cash Flow)
Investing (Cash Flow)
Financing (Cash Flow)
Free Cash Flow
Loading...
| Date | Operating (Cash Flow) | Investing (Cash Flow) | Financing (Cash Flow) | Free Cash Flow |
|---|---|---|---|---|
EPS
EPS (Diluted)
Loading...
| Date | EPS | EPS (Diluted) |
|---|---|---|
Outstanding Shares
Loading...
| Date | Outstanding Shares |
|---|---|
Recent 8-K/10-Q Filings
2024-05-08
Form 10-Q
ID: 0000950170-24-055701
2024-02-16
Form 8-K
ID: 0001193125-24-038534
2023-12-07
Form 8-K
ID: 0001193125-23-290340
2023-11-01
Form 10-Q
ID: 0000950170-23-057422
2023-11-01
Form 8-K
ID: 0000950170-23-057107
2023-10-12
Form 8-K
ID: 0001193125-23-255026
2023-10-11
Form 8-K
ID: 0001193125-23-254146
2023-08-02
Form 10-Q
ID: 0000950170-23-037151
2023-08-02
Form 8-K
ID: 0000950170-23-036758
2023-06-08
Form 8-K
ID: 0001193125-23-163542